Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3859582, 7 pages
https://doi.org/10.1155/2017/3859582
Research Article

Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma

1School of Life Sciences and Biotechnology, Shanghai Jiaotong University, Shanghai 200240, China
2Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
3Department of Medical Oncology, Shanghai Pulmonary Hospital, Cancer Institute, Tongji University Medical School, Shanghai 200433, China
4Key Lab of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
5Collaborative Innovation Center for Genetics and Development, Fudan University, Shanghai 200433, China
6School of Life Sciences, Shanghai University, Shanghai 200444, China

Correspondence should be addressed to Tao Huang; moc.621@oatgnauhot, Songwen Zhou; moc.621@newgnos_uohz, and Yu-Dong Cai; moc.621@duy_iac

Received 2 September 2016; Revised 28 September 2016; Accepted 22 November 2016; Published 8 February 2017

Academic Editor: Kazuhisa Nishizawa

Copyright © 2017 Chenglin Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Lockwood, Contemporary Issues in Women's Cancers, Jones and Bartlett Publishers, Sudbury, Mass, USA, 2009.
  2. A. Keen and E. Lennan, Women's Cancers, John Wiley & Sons, West Sussex, UK, 2011. View at Publisher · View at Google Scholar
  3. L. Ross, “2012 International Cancer Education Conference Proceedings,” Journal of Cancer Education, vol. 30, supplement 1, pp. 1–96, 2015. View at Publisher · View at Google Scholar
  4. Y. Chen, Q. Huang, Q. Chen et al., “The inflammation and estrogen metabolism impacts of polychlorinated biphenyls on endometrial cancer cells,” Toxicology in Vitro, vol. 29, no. 2, pp. 308–313, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Al-Zoughool, L. Dossus, R. Kaaks et al., “Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study,” International Journal of Cancer, vol. 121, no. 12, pp. 2741–2747, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. L. McCarroll, S. Armbruster, R. J. Pohle-Krauza et al., “Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application,” Gynecologic Oncology, vol. 137, no. 3, pp. 508–515, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Zhang, H. Liu, S. Yang, J. Zhang, L. Qian, and X. Chen, “Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis,” International Journal of Biological Markers, vol. 29, no. 1, pp. e21–e29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. T. Rabban, S. M. Calkins, A. N. Karnezis et al., “Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for lynch syndrome,” American Journal of Surgical Pathology, vol. 38, no. 6, pp. 793–800, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Y. Lee, H. J. Kim, E. H. Lee, H. W. Lee, J. Kim, and M. K. Kim, “One case of endometrial cancer occurrence: over 10 years after colon cancer in Lynch family,” Obstetrics & Gynecology Science, vol. 56, no. 6, pp. 408–411, 2013. View at Publisher · View at Google Scholar
  10. A. Dutt, H. B. Salvesen, H. Greulich, W. R. Sellers, R. Beroukhim, and M. Meyerson, “Somatic mutations are present in all members of the AKT family in endometrial carcinoma,” British Journal of Cancer, vol. 101, no. 7, pp. 1218–1219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. El Behery, M. H. Huda, E. M. Kamal, and A. E. Shehatta, “Diagnostic accuracy of uterine fluid lactate dehydrogenase isoenzyme activity profile and vaginal ultrasound in detecting endometrial cancer in women with postmenopausal bleeding,” Archives of Gynecology and Obstetrics, vol. 281, no. 4, pp. 717–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Neppe, R. Land, and A. Obermair, “Wrigley forceps to deliver a bulky uterus following a total laparoscopic hysterectomy for endometrial cancer,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 45, no. 5, pp. 444–445, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. A. Donovan, A. R. Boyington, P. L. Judson, and J. F. Wyman, “Bladder and bowel symptoms in cervical and endometrial cancer survivors,” Psycho-Oncology, vol. 23, no. 6, pp. 672–678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. E. S. Martens-Uzunova, R. Böttcher, C. M. Croce, G. Jenster, T. Visakorpi, and G. A. Calin, “Long noncoding RNA in prostate, bladder, and kidney cancer,” European Urology, vol. 65, no. 6, pp. 1140–1151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. O. Ribeiro, C. R. G. Schoof, A. Izzotti, L. V. Pereira, and L. R. Vasques, “MicroRNAs: modulators of cell identity, and their applications in tissue engineering,” MicroRNA, vol. 3, no. 1, pp. 45–53, 2014. View at Google Scholar · View at Scopus
  16. J.-H. Yoon, K. Abdelmohsen, and M. Gorospe, “Functional interactions among microRNAs and long noncoding RNAs,” Seminars in Cell and Developmental Biology, vol. 34, pp. 9–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J.-H. Yoon, K. Abdelmohsen, S. Srikantan et al., “LincRNA-p21 suppresses target mRNA translation,” Molecular Cell, vol. 47, no. 4, pp. 648–655, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. N. Weinstein, E. A. Collisson, G. B. Mills et al., “The Cancer Genome Atlas Pan-Cancer analysis project,” Nature Genetics, vol. 45, no. 10, pp. 1113–1120, 2013. View at Google Scholar
  19. Cancer Genome Atlas Research Network, “Integrated genomic analyses of ovarian carcinoma,” Nature, vol. 474, no. 7353, pp. 609–615, 2011. View at Google Scholar
  20. J. N. Weinstein, E. A. Collisson, G. B. Mills et al., “The cancer genome atlas pan-cancer analysis project,” Nature Genetics, vol. 45, no. 10, pp. 1113–1120, 2013. View at Google Scholar
  21. S. Luccioli, E. Ben-Jacob, A. Barzilai, P. Bonifazi, and A. Torcini, “Clique of functional hubs orchestrates population bursts in developmentally regulated neural networks,” PLoS Computational Biology, vol. 10, no. 9, Article ID e1003823, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Lin, D. P. Foster, and L. H. Ungar, “VIF regression: a fast regression algorithm for large data,” Journal of the American Statistical Association, vol. 106, no. 493, pp. 232–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Csardi and T. Nepusz, “The igraph software package for complex network research,” InterJournal Complex Systems, Article ID 1695, 2006. View at Google Scholar
  24. J. Zhao, S. Zhang, L.-Y. Wu, and X.-S. Zhang, “Efficient methods for identifying mutated driver pathways in cancer,” Bioinformatics, vol. 28, no. 22, pp. 2940–2947, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Vogelstein and K. W. Kinzler, “Cancer genes and the pathways they control,” Nature Medicine, vol. 10, no. 8, pp. 789–799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-H. Yeang, F. McCormick, and A. J. Levine, “Combinatorial patterns of somatic gene mutations in cancer,” The FASEB Journal, vol. 22, no. 8, pp. 2605–2622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Silies and C. Klämbt, “APC/CFzr/Cdh1-dependent regulation of cell adhesion controls glial migration in the Drosophila PNS,” Nature Neuroscience, vol. 13, no. 11, pp. 1357–1364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Q.-W. Deng, B.-S. He, Y.-Q. Pan et al., “Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 8, pp. 3705–3713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. R. Qian, T. Sano, K. Yoshimoto et al., “Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas,” Modern Pathology, vol. 20, no. 12, pp. 1269–1277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Płuciennik, M. Nowakowska, K. Pospiech et al., “The role of WWOX tumor suppressor gene in the regulation of EMT process via regulation of CDH1-ZEB1-VIM expression in endometrial cancer,” International Journal of Oncology, vol. 46, no. 6, pp. 2639–2648, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. S.-M. Hsiao, M.-W. Chen, C.-A. Chen et al., “The H3K9 methyltransferase G9a represses E-cadherin and is associated with myometrial invasion in endometrial cancer,” Annals of Surgical Oncology, vol. 22, pp. 1556–1565, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Banno, M. Yanokura, M. Iida, K. Masuda, and D. Aoki, “Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics,” Journal of Obstetrics and Gynaecology Research, vol. 40, no. 8, pp. 1957–1967, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zhang, T. Chao, R. Li et al., “MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a,” Journal of Molecular Medicine, vol. 87, no. 1, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Nanta, D. Kumar, D. Meeker et al., “NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128,” Oncogenesis, vol. 2, article no. e42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Fu, M. Rodova, R. Nanta et al., “NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200,” Neuro-Oncology, vol. 15, no. 6, pp. 691–706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Dong, H. Qiu, G. Du, Y. Wang, J. Yu, and C. Mao, “Restoration of microRNA-218 increases cellular chemosensitivity to cervical cancer by inhibiting cell-cycle progression,” Molecular Medicine Reports, vol. 10, no. 6, pp. 3289–3295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Peng, D. Li, M. Qin et al., “MicroRNA218 inhibits glioma migration and invasion via inhibiting glioma-associated oncogene homolog 1 expression at N terminus,” Tumor Biology, vol. 35, no. 4, pp. 3831–3837, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. L. A. Goff, J. Davila, M. R. Swerdel et al., “Ago2 immunoprecipitation identifies predicted MicroRNAs in human embryonic stem cells and neural precursors,” PLoS ONE, vol. 4, no. 9, Article ID e7192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Saito and K. Mimori, “Cancer stemness and circulating tumor cells,” Nihon rinsho. Japanese journal of clinical medicine, vol. 73, no. 5, pp. 806–810, 2015. View at Google Scholar · View at Scopus
  40. A. W. Fender, J. M. Nutter, T. L. Fitzgerald, F. E. Bertrand, and G. Sigounas, “Notch-1 promotes stemness and epithelial to mesenchymal transition in colorectal cancer,” Journal of Cellular Biochemistry, vol. 116, no. 11, pp. 2517–2527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. M. F. Alemdehy, J. R. Haanstra, H. W. J. de Looper et al., “Interstrand cross-link induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation,” Blood, vol. 125, no. 25, pp. 3937–3948, 2015. View at Publisher · View at Google Scholar
  42. Y. Chen, Y. Sun, L. Chen et al., “MiRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling,” Molecular Medicine Reports, vol. 7, no. 5, pp. 1579–1584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Chen, G. Zhao, F. Wang et al., “Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer,” Tumor Biology, vol. 35, no. 11, pp. 11081–11089, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. A.-Y. Gong, R. Zhou, G. Hu et al., “MicroRNA-513 regulates B7-H1 translation and is involved in IFN-γ-induced B7-H1 expression in cholangiocytes,” Journal of Immunology, vol. 182, no. 3, pp. 1325–1333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. N. S. Sakai, E. Samia-Aly, M. Barbera, and R. C. Fitzgerald, “A review of the current understanding and clinical utility of miRNAs in esophageal cancer,” Seminars in Cancer Biology, vol. 23, no. 6, pp. 512–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Li, X. Li, W. Cao, Y. Qi, and X. Yang, “Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin,” Acta Histochemica, vol. 116, no. 5, pp. 723–729, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Romero-Pérez, M. Á. López-García, J. Díaz-Martín et al., “ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma,” Modern Pathology, vol. 26, no. 11, pp. 1514–1524, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Leroy, M. Anderson, and T. Soussi, “TP53 mutations in human cancer: database reassessment and prospects for the next decade,” Human Mutation, vol. 35, no. 6, pp. 672–688, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Chmelarova, S. Kos, E. Dvorakova et al., “Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium,” Clinical Chemistry and Laboratory Medicine, vol. 52, no. 8, pp. 1229–1234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Ganci, A. Sacconi, N. B. Ben-Moshe et al., “Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients,” Annals of Oncology, vol. 24, no. 12, pp. 3082–3088, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. K. Cheah, R. W. Cheng, S. K. Yeap, C. H. Khoo, and H. S. See, “Analysis of TP53 gene expression and p53 level of human hypopharyngeal FaDu (HTB-43) head and neck cancer cell line after microRNA-181a inhibition,” Genetics and Molecular Research, vol. 13, no. 1, pp. 1679–1683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Dufour, G. Palermo, E. Zellmeier et al., “Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients,” Blood, vol. 121, no. 18, pp. 3650–3657, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Zhang, L. Geng, G. Talmon, and J. Wang, “MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer,” Journal of Biological Chemistry, vol. 290, no. 10, pp. 6215–6225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. D. J. McKenna, S. S. McDade, D. Patel, and D. J. McCance, “MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6,” Journal of Virology, vol. 84, no. 20, pp. 10644–10652, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. A. Li, Y. Chen, J. Zhao, F. Kong, and Y. Zhang, “miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression,” Cancer Letters, vol. 304, no. 1, pp. 52–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Léveillé, C. A. Melo, K. Rooijers et al., “Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA,” Nature Communications, vol. 6, article no. 6520, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Sánchez, V. Segura, O. Marín-Béjar et al., “Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature,” Nature communications, vol. 5, article 5812, p. 5812, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Zhang, M. Xu, and Y.-Y. Mo, “Role of the lncRNA-p53 regulatory network in cancer,” Journal of Molecular Cell Biology, vol. 6, no. 3, pp. 181–191, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. X.-H. Liu, M. Sun, F.-Q. Nie et al., “Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer,” Molecular Cancer, vol. 13, no. 1, article 92, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. M. R. Epis, K. M. Giles, P. A. Candy, R. J. Webster, and P. J. Leedman, “MiR-331-3p regulates expression of neuropilin-2 in glioblastoma,” Journal of Neuro-Oncology, vol. 116, no. 1, pp. 67–75, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. M. R. Epis, A. Barker, K. M. Giles, D. J. Beveridge, and P. J. Leedman, “The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells,” The Journal of Biological Chemistry, vol. 286, no. 48, pp. 41442–41454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J.-H. Yoon, K. Abdelmohsen, and M. Gorospe, “Posttranscriptional gene regulation by long noncoding RNA,” Journal of Molecular Biology, vol. 425, no. 19, pp. 3723–3730, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Terakawa, H. Kenzaki, and S. Takada, “P53 searches on DNA by rotation-uncoupled sliding at C-terminal tails and restricted hopping of core domains,” Journal of the American Chemical Society, vol. 134, no. 35, pp. 14555–14562, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. K. Mungamuri, S. Wang, J. J. Manfredi, W. Gu, and S. A. Aaronson, “Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters,” Oncogene, vol. 34, no. 19, pp. 2461–2470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Shi, B. Zhang, X. Sun et al., “MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1,” British Journal of Cancer, vol. 111, no. 12, pp. 2316–2327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. H. Xiong, Q. Li, S. Liu et al., “Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma,” PLOS ONE, vol. 9, no. 10, Article ID e110163, 2014. View at Publisher · View at Google Scholar · View at Scopus